Effect of Low-level Red-light on Ultra-high Myopia

NCT06738095 | Completed

• 1 other identifier: BeijingTH TRECKY239
• Study Type: interventional
• Target: 57
• Locations: 1 country
• Sites: 1

Brief Summary

100 eyes of ultra-high myopia were treated with daily low-level red-light. The age of children ranged from 3 to 16.3 years. The follow-up duration was one year. The objective was to explore the effect of daily low-level red-light on ultra-high myopia treatment

Conditions

Myopia

Outcome Measures

Primary Outcomes (1)

• Changes in axial length

  One year changes in axial length

  one year

Study Arms (1)

red-light

EXPERIMENTAL

Children with ultra-high myopia were treated with daily low-level red-light, which was used twice a day, with four hours interval. Three minutes for each session of treatment

Device: daily low-level red-light

Interventions

daily low-level red-light DEVICE

Daily low-level red-light is a kind of myopia intervention. Red-light typically using 650-nm wave of length. The treatment duration last 3 minutes each time, every day children were anticipated to use two times, at home.

red-light

Eligibility Criteria

• Age: 3 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• A. The age is over 3 years old and under 18 years old. B. The spherical equivalent error is ≤ -6 D diopter . D. be able to cooperate to complete various eye examinations. E. be able to attend follow-up according to the specified time. F the guardian can accompany the use of the instrument.

You may not qualify if:

• A. Complications associated with high myopia (such as choroidal neovascularization, macular split or hole, Rhegmatogenous retinal detachment); B other macular diseases (central serous retinopathy) or other eye diseases (e.g.Glaucoma, cataract, uveitis); C complicated with photosensitivity, psoriasis, albinism, hyperactivity disorder, nephrotic syndrome and systemic erythema Immune system diseases such as lupus; D. other systemic diseases or pregnancy; E. other similar instruments have been used for treatment in the past six months.
• F. can't cooperate to complete various eye examinations. G. The guardian cannot accompany the use of this instrument.

Sponsors & Collaborators

• Beijing Tongren Hospital: lead

Study Sites (1)

Beijing Tongren Hospital

Beijing, China, China

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive Errors; Eye Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr

Study Record Dates

• First Submitted: December 13, 2024
• First Posted: December 17, 2024
• Study Start: January 18, 2022
• Primary Completion: August 23, 2022
• Study Completion: August 23, 2022
• Last Updated: December 17, 2024

Record last verified: 2022-01

Locations

CN (1)